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ABSTRACT: Owing to their favorable molecular topology, atro-
pisomers represent particularly valuable chiral scaffolds for nu-
merous applications throughout academic research and industry. 
Nevertheless, whereas various well-established catalyst-controlled 
methodologies allow addressing stereocenter configuration, effi-
cient procedures to prepare axially chiral compounds in high iso-
meric purity are still scarce. Complementary to the comprehensive reviews in the area, this perspective article features representative 
advances for the catalyst-stereocontrolled synthesis of atropisomeric scaffolds. With a focus on axially chiral motifs frequently uti-
lized in catalysis or medicinal chemistry, selected recent examples encompassing unique stereoselective transition metal, hydrogen 
bond, ion pairing, chiral phosphoric acid, and amine catalysis are highlighted. 
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Controlling the spatial arrangement of substituents within a 
molecular framework is of fundamental importance not only to 
affect the intrinsic properties of a specific molecule, but also to 
influence intermolecular interactions, for instance with sub-
strates in catalytic processes or biological systems.1 
Atropisomers, stereoisomers arising from a restricted rota-
tion about a single bond, are structurally particularly well de-
fined and allow a predictable and precise alignment of relevant 
residues. The hallmarks of atropisomers are well established in 
catalyst design and are also increasingly recognized in medici-
nal chemistry.2 While the structural diversity of atropisomers is 
remarkable, the prototypical biaryls had an extraordinary im-
pact in the field of homogeneous catalysis.3 In contrast, methods 
to prepare isomerically enriched atropisomers by stereoselec-
tive catalysis are still limited to selected structural entities.  
Nevertheless, various elegant strategies were recently de-
veloped to address the constraints of the catalyst-controlled ste-
reoselective synthesis of atropisomers, which are typically 
based on atroposelective cross-coupling, the de novo construc-
tion of arenes, desymmetrization, or the conversion of a stereo-
dynamic system.4 These different approaches offer an increas-
ing structural diversity of atropisomers, for instance to provide 
a means to impart stereochemical information in catalytic pro-
cesses or to allow the development of stereochemically com-
plex atropisomeric pharmaceuticals. Herein, we highlight a se-
lection of examples concerning the stereoselective syntheses of 
axially chiral compounds, which enable the preparation of a 
plethora of novel atropisomeric compounds with application in 
catalysis and medicinal chemistry. For a comprehensive over-
view on axial chirality, we refer to excellent review articles in 
the field.4  
 
1. ATROPISOMERIC CATALYSTS 
Since racemic 1,1'-bi-2-naphthol (BINOL) can be obtained 
in bulk amounts from the oxidative dimerization of 2-naphthol5 
and the enantiomers resolved by various methods,6 the binaph-
thol scaffold is a frequently utilized motif in homogeneous ca-
talysis and the starting material for various derivatives. Further-
more, the (Sa)-1,1'-bi-2-naphthol can be prepared selectively by 
a copper-catalyzed dimerization in presence of (S)-ampheta-
mine as ligand.7 
However, synthetic strategies that allow for more structural 
variability are highly desirable. An elegant approach was re-
cently shown by Smith and co-workers, where treatment of ra-
cemic 1-aryl-2-tetralones (1) with benzyl iodide in the presence 
of a base and a chiral cinchona-derived ammonium salt (5) af-
fords the corresponding benzylated enol ether (2) with excellent 
stereoselectivity (Scheme 1).8 Controlled by the ion-pairing 
catalyst 5, a base-promoted formation of rotationally restricted 
enolates is followed by atroposelective O-alkylation with ben-
zyl iodide by means of a dynamic kinetic resolution of the start-
ing material. To diversify the obtained scaffold, the obtained 
products were oxidized with DDQ, giving the corresponding 
protected aromatic diol (3) in excellent yields and with retention 
of optical purity. Furthermore, deprotection with BBr3 affords 
both C1- and C2-symmetric binaphthols (4), which grant access 
to catalysts whose steric and electronic properties differ from 
typical BINOL derivatives. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Atroposelective O-Alkylation  
To further extend the scope of axially chiral biaryl diol syn-
thesis beyond binaphthyl systems, Gu and co-workers recently 
reported a palladium-catalyzed atroposelective synthesis of 2-
aryl-2-cyclohexenones (8) through a Suzuki cross-coupling of 
2-iodo-2,3-unsaturated enones (6) with trisubstituted aromatic 
boronic acids or boronic esters (7) (Scheme 2).9 The transfer of 
the stereochemical information was achieved by the employ-
ment of a bidentate ferrocenyl aminophosphine ligand (9). The 
obtained axially chiral enones are configurationally stable pre-
cursors of the 2,2’-biphenol scaffolds and of other biaryl and 
non-biaryl structures, such as carbazoles, quinones or 
haloarenes, which are accessible without diminishing the enan-
tiomeric excess of the starting enone (8).  
 
 
 
 
 
 
 
 
 
Scheme 2. Selective Synthesis of Arylcyclohexenones 
By substitution of the hydroxy with amino groups, the 
BINAM scaffold with widespread application in catalysis is ob-
tained.10 The classical synthesis of BINAM relies on the oxida-
tive homocoupling of 2-naphthylamine and subsequent separa-
tion of the enantiomers.11 The development of stereoselective 
methods that give access to BINAM and related substituted 
1,1’-binaphthyl-2,2’-diamines with high enantiomeric purity 
would thus be highly desirable. An elegant solution to this prob-
lem was reported by the groups of List and Kürti, disclosing a 
chiral phosphoric acid-catalyzed atroposelective rearrangement 
of symmetric benzidines (10). The procedure allows the prepa-
ration of C2-symmetric BINAM derivatives (11, Scheme 3) 
with excellent selectivity and catalytic amount of chiral phos-
phoric acids, while the original work by Sannicolò employed an 
excess of camphor sulphonic acid.12 Furthermore, the use of ax-
ially chiral phosphoric acids also proved to be a particularly ef-
fective catalyst for the conversion of quinones and iminoqui-
nones to form axially chiral biaryl diols, which in turn enriches 
the scope of the selective synthesis of atropisomeric diols.13  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Atroposelective Benzidine Rearrangement  
Since the discovery of BINAP by Noyori, axially chiral bi- 
and monodentate phosphines have found widespread applica-
tion in asymmetric catalysis.14 Binaphthyl phosphines are fre-
quently prepared from BINOL, which however limits the struc-
tural variability of the catalysts. Methods that allow to directly 
obtain unsymmetrical ligands with different degree of substitu-
tion in a selective reaction are thus especially valuable. By con-
sidering a de novo ring construction approach, Tanaka reported 
a highly enantioselective [2+2+2]-cycloaddition of alkynyl 
phosphine oxides (15) and symmetrical 1,6-diynes (14) 
(Scheme 4).15 The reaction is catalyzed by a rhodium/H8-
BINAP complex and proceeds under mild conditions, affording 
the target QUINAP-type phosphine oxide (16) in high yields 
and selectivity. Subsequent reduction of the phosphine oxides 
affords the QUINAP-type ligand, as shown by the reaction of 
(17) with HSiCl3, which yields the target P,N-ligand (18) with-
out affecting the enantiomeric purity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. De novo Synthesis of Substituted QUINAPs and 
their application  
  
Fascinated by the biosynthesis of aromatic polyketides, our 
group developed a stereoselective arene-forming aldol conden-
sation of ketoaldehydes (19) with a proline-derived catalyst (21) 
(Scheme 5).16 The reaction proceeds under mild conditions, af-
fording the corresponding atropisomeric biaryl (20) in high 
yields and enantiomeric excess. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Biomimetic atroposelective aldol condensation 
 
We further expanded the scope of the atroposelective aldol 
condensation by studying the synthesis of configurationally sta-
ble oligo-1,2-naphthylenes with multiple stereogenic axes 
(Scheme 6).17 The procedure relies on the iterative addition 
of a building block, oxidation of the diol to the corresponding 
ketoaldehyde (22) and a catalyst- or substrate-controlled stere-
oselective aldol condensation. The configurational stability of 
the products (23) provides particularly well-defined molecular 
scaffolds.  
 
 
 
 
 
 
 
 
 
Scheme 6. Diastereoselective synthesis of oligo-1,2-naph-
thylenes 
The Suzuki cross-coupling has seen great progress in the 
stereoselective synthesis of atropisomers.18 In a seminal study 
by Buchwald, a catalyst-controlled atropoenantioselective syn-
thesis of phosphonates was reported, where the employment of 
an axially chiral aminophosphine ligand afforded the biaryl 
phosphine precursor in high yields and selectivity.19 Taking ad-
vantage of the substrate tolerance of the Suzuki reaction, 
Suginome and co-workers recently illustrated that 1-bromo-2-
naphthylphosphonates (24) can be successfully coupled with a 
variety of substituted arylboronic acids (25).20 Intriguingly, chi-
ral polymeric quinoxaline with a covalently bound biar-
ylphosphine (27) (PQXphos) could be employed, whose con-
figuration is induced by the helicity of the polymer itself 
(Scheme 7). Interestingly, the helicity of PQXphos can be 
switched by heating of the catalyst, which allows an inversion 
of selectivity (98% ee) for the same cross-coupling reaction. 
The obtained biaryl phosphonates can be further converted to 
different C1-symmetric phosphines, which can be used as novel 
ligands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7. Atroposelective Suzuki Reaction Catalyzed 
by Helically Chiral Phosphines 
 
Gu and co-workers took advantage of the properties of pal-
ladium carbenes and illustrated an elegant procedure for the en-
antioselective synthesis of axially chiral vinyl arenes.21 The re-
action involves the coupling of 1-bromo-2-naphthylphosphine 
oxides (29) with tetralone-derived tosylhydrazones (28) in the 
presence of palladium acetate and a chiral phosphoramidite lig-
and (31) (Scheme 8). Under these conditions, the hydrazone 
was converted to the corresponding diazo compound that is able 
to form a palladium carbene with the oxidative addition com-
plex. Migration and subsequent β-hydride elimination thus af-
fords the target axially chiral phosphine oxides (30) in high 
yields and enantiomeric excess. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 8. Palladium-catalyzed Atroposelective Synthesis of 
Vinylaryl-Phosphine Oxides 
To demonstrate the utility of the obtained compounds, the 
phosphine oxide (32) was reduced to the corresponding phos-
phine (33) in almost quantitative yields and with retention of 
enantiomeric excess. The newly synthesized ligand was em-
ployed in the palladium-catalyzed asymmetric allylic alkylation 
between 1,3-diphenylallyl acetate (35) and an indole-derived 
substrate (34). The resulting N-allylated indole (36) was ob-
tained in 88% yield with 83% ee, corroborating the utility of 
this new class of axially chiral olefins (Scheme 9). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9. Synthesis of Chiral P,Olefin Ligand and Applica-
tion in the Asymmetric Allylic Alkylation 
An alternative approach to obtain axially chiral phosphine–
olefin ligands was shown by Yang.22 The reaction takes ad-
vantage of the low rotational barrier of biaryl phosphine oxides 
(37), which are prone to undergo a dynamic kinetic resolution 
in the presence of a terminal olefin (38), Pd(OAc)2 and Boc-
protected valine as the ligand, giving the corresponding biaryl 
phosphine oxide (39) with up to 99% yield and up to 96% ee 
(Scheme 10).  
 
 
 
 
 
 
 
 
Scheme 10. Palladium-catalyzed atroposelective C-H ole-
fination  
2. BIOACTIVE ATROPISOMERS 
Initially targeting the synthesis of bioactive compounds as 
racemic mixtures, medicinal chemistry evolved towards the 
synthesis of single stereoisomers. In this context, atropisomers 
received increasing interest due to their unique properties and 
importance in natural product chemistry. Because of their struc-
tural complexity, the development of efficient processes to se-
lectively obtain bioactive atropisomers nevertheless remained 
challenging. Furthermore, depending on steric interactions of 
the groups that hinder rotation, the degree of configurational 
stability of atropisomer drugs needs to be carefully considered 
throughout their preparation and under physiological condi-
tions. Clayden and LaPlante classified atropisomers in drug dis-
covery into three categories according to their rotational energy 
barrier and half-life of racemization at room temperature.2, 23 
Class 1 compounds exhibit a half-life of racemization of sec-
onds and a ∆Erot < 20 kcal.mol-1. These atropisomers are hence 
equilibrating rapidly under physiological conditions. On the 
other end, class 3 entities with a ∆Erot ≥ 30 kcal.mol-1 are stable 
for years and can be produced as single atropisomers. Com-
pounds within class 2 are however critical in their handling, as 
their half-life of racemization ranges from seconds to years. 
Therefore, class 2 structures are usually modified to obtain ei-
ther class 1 or class 3 compounds, mostly by modulating the 
size of interacting groups. 
In the biosynthesis of atropisomeric natural products, an en-
zyme-catalyzed assembly of two molecular moieties frequently 
results in the stereoselective construction of a C–C or C–N 
bond. These oxidative biaryl couplings are typically catalyzed 
by laccases, cytochrome P450 or peroxidases and in most cases, 
the enzymes impart stereoselectivity.24 Müller demonstrated 
that certain cytochrome P450 enzymes are able to catalyze an 
atroposelective oxidative biaryl coupling of fungal natural 
products.25 This study highlighted the fundamental implication 
of cytochrome P450 enzyme KtnC, from Aspergillus niger, in 
the dimerization process of the coumarin 7-demethylsiderin to 
produce a single enantiomer of P-orlandin. Similarly, cyto-
chrome P450 enzyme DesC from Emetricella desertorum effi-
ciently converts the same precursor into another isomer, M-
desertorin A (Scheme 11). The catalytic activity of KtnC and 
DesC, holds great promises for future applications. 
 
 
 
 
 
 
Scheme 11.  Biosynthesis of P-orlandin and M-desertorin A 
by cytochrome P450 enzymes 
As alternative to the design of promiscuous enzymes, robust 
processes involving small molecule catalysts have received 
considerable attention. For instance, Shaw utilized a tert-leu-
cine-BINOL derived vanadium complex for a related coupling 
of two naphthylpyranone units in the total synthesis of (–)-virdi-
toxin.26 This efficient reaction led to the tetra-ortho substituted 
biaryl intermediate with excellent diastereoselectivity (95:5) 
(Scheme 12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12. Total Synthesis of (–)-Viridotoxin 
For scaffolds with restricted rotation about a C–N bond, 
Bencivenni, studied a new class of succinimides, a type of com-
pounds well-known for their anti-seizure properties (Scheme 
 13).27 An atroposelective Diels-Alder reaction catalyzed by a 
chiral primary amine allowed the successful desymmetrization 
of N-arylmaleimides, giving rise to a large range of heteroaryls 
displaying three stereocenters as well as a stereogenic axis. No-
tably, the sterically demanding tert-butyl substituent in the or-
tho position is fundamental for sufficiently restricting the 
rotation about the C-N axis.  
 
 
 
 
 
 
 
 
 
 
 
Scheme 13. Stereoselective desymmetrization of N-arylma-
leimides 
In a seminal atroposelective bromination of 3-ar-
ylquinazolin-4(3H)-ones, Miller and co-worker describe a con-
cept for the synthesis of a large variety of potentially bioactive 
scaffolds (Scheme 14).28 The approach consisting of a short 
peptide-catalyzed halogenation allowed the selective introduc-
tion of bulky bromine substituents in both ortho positions of the 
phenyl moiety, thus restricting the rotation about the C–N bond. 
A broad scope of quinazolinone derivatives was thus obtained 
with excellent yield and enantioselectivity. Furthermore, some 
of these precursors were functionalized by different cross-cou-
pling reactions to give multiple drug-like molecules without 
loss of enantiomeric purity. The quinazolinone ring is a motif 
widely spread among compounds exhibiting various biological 
properties, these scaffolds could have intriguing applications in 
medicinal chemistry.29 
 
 
 
 
 
 
 
 
Scheme 14. Atroposelective bromination of 3-ar-
ylquinazolin-4(3H)-ones 
Furthermore, Asano and Matsubara disclosed the synthesis 
of halogenated axially chiral 8-arylquinolines (Scheme 15).30 
Catalyzed by a bifunctional quinidine-urea derivative (56), the 
atroposelective bromination provided arylquinoline derivatives 
with excellent yield and enantioselectivity, thus potentially al-
lowing further functionalization into complex bioactive atro-
pisomers. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 15. Atroposelective halogenation of 8-arylquino-
lines 
Starting from di-ortho-substituted aromatic anilides, Maru-
oka reported an enantioselective synthesis of anilides by intro-
ducing a substituent directly at the nitrogen.31 An alkylation cat-
alyzed by a chiral tetraalkylammonium bromide salt allowed 
the conversion of secondary into tertiary anilides, that suitably 
prevents the rotation about the Ar–N bond (Scheme 16). With 
a low catalyst loading, a large variety of axially chiral anilides 
could be prepared with excellent yields and enantioselectivity. 
Those scaffolds were further derivatized, without erosion of en-
antiomeric purity and are of potential use in medicinal chemis-
try. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 16.  Synthesis of axially chiral anilides 
The de novo construction of a rotationally restricted struc-
ture often allows for a convergent synthesis of atropisomers, a 
strategy that Gong explored for the atroposelective synthesis of 
boron-based heteroaryls (Scheme 17).32 A gold-catalyzed cy-
cloisomerization-amination cascade reaction allowed the stere-
oselective construction of a variety of heteroaryls. The protect-
ing groups on the diazene are thus responsible for the restricted 
rotation about the C–N bond of the corresponding hydrazide. 
The postulated mechanism involves an initial coordination of 
the Au(I) complex to the alkyne to form a vinylgold intermedi-
ate. The latter is added to the diazene, itself coordinated to a 
chiral gold complex, giving rise to a configurationally stable ax-
ially chiral compound. 
Due to their unique properties, boron-containing com-
pounds have been studied in medicinal chemistry as new class 
of bioactive molecules.33 Their reversible interaction with pro-
teins and the adjustability of their Lewis acidity make them an 
interesting target in drug discovery. 
 
 
 
  
 
 
 
Scheme 17. Gold-catalyzed atroposelective synthesis of 
amino-oxaborininol dervivatives 
By using an earth abundant metal combined with an organo-
catalyst, Tan developed an atroposelective synthesis of arylpyr-
roles, a motif largely found among natural products (Scheme 
18).34 A Paal-Knorr reaction catalyzed by a chiral phosphoric 
acid, with iron (III) triflate as a Lewis acid, led to a diversity of 
axially chiral arylpyrroles with excellent yields and enantiose-
lectivity. After the formation of a key enamine intermediate, the 
chiral phosphoric acid catalyzes the dehydrative cyclization re-
sulting in the formation of the atropisomer. The rotation about 
the C–N bond was sufficiently suppressed by the ortho substit-
uents on the pyrrole moiety and the aryl ring.  
 
 
 
 
 
 
Scheme 18. Atroposelective Paal-Knorr for the synthesis of 
arylpyrrole derivatives 
Seidel disclosed a biomimetic approach for the synthesis of 
isoindolinones cores and mariline A (Scheme 19).35 A particu-
larly low catalyst loading of chiral phosphoric acid promoted 
the intramolecular condensation between 2-acyl-benzaldehyde 
derivatives and anilines, enabling the construction of several 
isoindolinones with excellent enantioselectivity. The steric in-
teractions of the ortho-tert-butyl ortho-group with the isoindo-
linone substituents provided sufficient rotational restriction 
about the stereogenic C–N bond. 
 
 
 
 
 
 
 
 
 
 
Scheme 19. Axially chiral synthesis of indolinones 
Catalyzed by pyrrolidinyl tetrazole 21, our group elaborated 
a stereoselective synthesis of axially chiral aromatic amides by 
the stereoselective arene-forming aldol condensation (Scheme 
20).36 Aryl amides are frequently utilized motifs in drug devel-
opment2 and axially chiral congeners with restricted rotation 
about the Ar–CO bond were obtained in enantioenriched form. 
 
 
 
 
 
 
 
Scheme 20. Stereoselective synthesis of axially chiral aro-
matic amides 
An elegant Hantzsch-type reaction for the atroposelective 
synthesis of 4-arylpyridines was recently described by Bressy, 
Bugaut and Rodriguez (Scheme 21).37 The enantioselective Mi-
chael addition catalyzed by a chiral thiourea derivative was fol-
lowed by the condensation with an ammonium acetate salt, giv-
ing rise to 1,4-dihydropyridines. By central-to-axial chirality 
conversion during the MnO2 oxidation, a variety of axially chi-
ral 4-arylpyridine derivatives where obtained, a general scaffold 
comprising members with anti-tumor and antiviral properties.38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 21. Atroposelective Hantzsch-type synthesis of 4-ar-
ylpyridines 
4. CONCLUSION 
Various conceptually distinct methods for the catalyst-con-
trolled, stereoselective synthesis of atropisomers are emerging, 
making an increasing range of axially chiral scaffolds available. 
Elegant strategies that allow the transfer of the stereochemical 
information of readily available catalysts into important atro-
pisomeric structures have been elaborated. As atropisomers al-
low a predictable relative arrangement of groups in space, their 
utility as structurally well-defined scaffold has been corrobo-
rated. For catalyst design and in medicinal chemistry, chiral at-
ropisomeric motifs are therefore receiving a privileged position. 
It can be concluded, that with methods becoming available for 
their synthesis, that the various types of atropisomers will find 
widespread applications in several research fields.  
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